Search results for "bowel"

showing 10 items of 637 documents

Immunomodulatory drugs: Oral and systemic adverse effects

2013

Objectives: The main objectives are to present the different adverses effects of the immunomodulatory drugs that can impair the quality of life of the immunosupressed patients and study the impact of immunomodualtion on oral diseases. Immunomodulatory drugs have changed the treatment protocols of many diseases where immune functions play a central role, such as rheumatic diseases. Their effect on oral health has not been systematically investigated, however. Study Design: We review current data on the new immunomodulatory drugs from the oral health perspective based on open literature search of the topic. Results: These target specific drugs appear to have less drug interactions than earlie…

DrugPathologymedicine.medical_specialtymedia_common.quotation_subjectPlacebo-controlled studyOdontologíaReviewBioinformaticsInflammatory bowel diseaselaw.inventionImmune systemRandomized controlled triallawmedicineHumansImmunologic FactorsAdverse effectGeneral Dentistrymedia_commonOral Medicine and PathologyLupus erythematosusbusiness.industry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludstomatognathic diseasesOtorhinolaryngologyRheumatoid arthritisUNESCO::CIENCIAS MÉDICASSurgeryMouth DiseasesbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Aerosolized GLP-1 for Treatment of Diabetes Mellitus and Irritable Bowel Syndrome

2014

Diabetes is a global burden and the prevalence of the disease, in particular diabetes mellitus type 2 is rapidly increasing worldwide. After introduction of insulin into clinical therapy about 90 years ago a major number of pharmaceuticals has been developed for treatment of diabetes mellitus type 2. One of these, the incretin glucagon-like peptide 1 (GLP-1), like insulin, needs subcutaneous administration causing inconvenience to patients. However, administration of GLP-1 plays also a role for treatment of irritable bowel syndrome (IBS). To improve patient convenience inhaled insulin (Exubera®) was developed and approved but failed market acceptance some years ago. Recently, another inhala…

Drugendocrine systemmedicine.medical_specialtyInhalationbusiness.industrymedia_common.quotation_subjectInsulinmedicine.medical_treatmentdigestive oral and skin physiologyIncretinDiseasemedicine.diseaseGlucagon-like peptide-1Diabetes mellitusInternal medicinemedicinebusinesshormones hormone substitutes and hormone antagonistsIrritable bowel syndromemedia_common
researchProduct

Guanosine prevents nuclear factor-κB nuclear translocation ameliorating experimental colitis in rats

2018

Background inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC), are prevalent and debilitating health problems worldwide. Due to the adverse effects of classical treatment for IBD, therapeutic options and approaches for these diseases continue to evolve. Guanosine, a guanine-based purine, is an extracellular signalling molecule that seems to exert anti-inflammatory and antioxidative effects in several in vivo and in vitro injury models. The aim of the present study was to investigate whether exogenous guanosine may have protective effects on 2,4-dinitrobenzene sulfonic acid (DNBS)-induced Colitis in rat. Methods Experimental Colitis was induced by …

EXPERIMENTAL COLITIS GUANOSINE INFLAMMATORY BOWEL DISEASESettore BIO/09 - Fisiologia
researchProduct

New therapeutic strategies for treatment of inflammatory bowel disease

2008

Although the precise etiology of inflammatory bowel disease (IBD) still remains unclear, considerable progress has been made in the identification of cytokine-mediated signaling pathways involved in the inflammatory process. Recent data have clearly shown that these pathways induce augmented intestinal T-cell activation and thus resistance to apoptosis, which is a central process in disease pathogenesis, as it impairs mucosal homeostasis. Therefore, novel therapeutic strategies aim at restoring activated effector T-cell susceptibility to apoptosis in the gut, based on a pathophysiological rationale. This development is best exemplified by the emergence of agents that target the TNF pathway,…

EffectorT-LymphocytesImmunologyApoptosisDisease pathogenesisBiologyInflammatory Bowel Diseasesmedicine.diseaseInflammatory bowel diseaseCytokines metabolismApoptosisDrug DesignImmunologymedicineCytokinesHumansImmunology and AllergyTumor necrosis factor alphaIntestinal MucosaSignal transductionMucosal homeostasisMucosal Immunology
researchProduct

IL-12 family members in experimental colitis

2008

Interleukin (IL)-12 p35/p40 is a heterodimeric cytokine that plays an important role in T helper (Th) cell polarization and Th1 T-cell differentiation. Recent findings have shown that both p35 and p40 can form other cytokines with different proteins (IL-23: p19/p40; IL-35: p35/EBI3). Furthermore, the cytokine IL-27 (EBI3/p28) has been identified as a member of the IL-12 family. Here, we discuss the recent findings on the role of IL-12 family members in experimental colitis. In particular, the role of IL-23 as a master regulator of effector T-cell activation is highlighted. These findings have important implications for the design of new therapeutic approaches in chronic intestinal inflammat…

EffectorT-Lymphocytesmedicine.medical_treatmentImmunologyInterleukinMaster regulatorExperimental colitishemic and immune systemsEBI3BiologyColitisInflammatory Bowel DiseasesInterleukin-12CytokineIntestinal inflammationImmunologyInterleukin 12medicineAnimalsHumansImmunology and AllergySignal TransductionMucosal Immunology
researchProduct

Regulatory T cells--the renaissance of the suppressor T cells.

2007

Immune reactions are stringently regulated and balanced by complex interactions of stimulating and suppressing mechanisms. Dysfunctions of this sophisticated immune regulatory network can lead to a variety of diseases such as autoimmunity, allergy, cancer, and pregnancy disorders. The rediscovery of suppressor T cells a decade ago--now designated as T regulatory cells--set off a huge avalanche of research activities leading to a multitude of preclinical and clinical studies. Herein, we give a comprehensive review about this research on T regulatory cells and the relevance of this suppressive T cell population for the development of innovative immune therapeutic strategies.

Encephalomyelitis Autoimmune Experimentalmedicine.medical_treatmentT cellPopulationAutoimmunitymedicine.disease_causeInfectionsT-Lymphocytes RegulatoryAutoimmunitylaw.inventionMiceImmune systemlawPregnancyT-Lymphocyte SubsetsTransplantation ImmunologyNeoplasmsmedicineSuppressor Factors ImmunologicAnimalsHumanseducationeducation.field_of_studybusiness.industryModels ImmunologicalGeneral MedicineT lymphocyteImmunotherapyInflammatory Bowel DiseasesTransplantationDisease Models Animalmedicine.anatomical_structureDiabetes Mellitus Type 1ImmunologySuppressorFemaleImmunotherapybusinessAnnals of medicine
researchProduct

Advances in endoscopic imaging of colorectal neoplasia.

2010

Colon cancer screening is arguably the most important activity performed by gastroenterologists. Recent decreases in rates of death from colorectal cancer indicate that screening methods such as colonoscopy have a positive impact. There is still room for improvement, however, particularly in prevention of right-sided colon cancer. Practice issues, such as making colonoscopy more comfortable, safer, and less costly, are keys to continued success in cancer prevention. Colonoscopy techniques, technologies, and quality control measures have advanced to improve detection, classification, and removal of early neoplasias. In particular, slow, careful inspection of the colon by gastroenterologists …

Endoscopic ultrasoundmedicine.medical_specialtyColorectal cancerColonPopulationColonoscopyColonic PolypsInflammatory bowel diseaseChromoendoscopyEndosonographyPredictive Value of TestsImage Interpretation Computer-AssistedEndomicroscopyMedicineHumansMass ScreeningeducationEarly Detection of Cancereducation.field_of_studyCancer preventionHepatologymedicine.diagnostic_testColonoscopesbusiness.industryGastroenterologyColonoscopyEquipment Designmedicine.diseaseRadiologybusinessColorectal NeoplasmsPrecancerous ConditionsGastroenterology
researchProduct

Traumatic Isolated Intramural Duodenal Hematoma Causing Intestinal Obstruction

2015

A 21-year-old man was admitted 36 hours after a blunt abdominal trauma occurred during a sporting competition. He complained of colic epigastric abdominal pain, nausea, and vomiting. He was hemodynamically stable; blood counts and metabolic panel were normal. Abdominal CT showed an intestinal obstruction caused by an 8 x 6 x 11 cm hematoma on the right lateral duodenal wall without signs of active bleeding (Figure 1). He underwent gastric decompression and started total parenteral nutrition and intravenous pump inhibitors. Esophagogastroduodenoscopy (EGD) performed 48 hours after the diagnosis showed an extrinsic compression by a bluish obstruction in the first part of the duodenum resembli…

Endoscopic ultrasoundmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryEsophagogastroduodenoscopyGeneral Medicinemedicine.diseaseAsymptomaticSmall BowelSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureHematomaAbdominal traumaDuodenal bulbImagemedicineDuodenumVomitingmedicine.symptombusinessTrauma Duodenal Hematoma Intestinal ObstructionACG Case Reports Journal
researchProduct

Inflammatory Bowel Diseases

1979

The endoscopic aspects of an inflammatory colon disease do not permit the differentiation of a nonspecific proctitis from a bacterial enterocolitis and an ulcerative proctitis.

Enterocolitismedicine.medical_specialtybusiness.industryInflammatory Bowel DiseasesDiseasePseudomembranous colitismedicine.diseaseGastroenterologyUlcerative colitisdigestive system diseasesIschemic colitisUlcerative proctitisInternal medicineMedicinemedicine.symptombusinessProctitis
researchProduct

Diagnosis of chronic anaemia in gastrointestinal disorders: a guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (…

2019

Anaemia is a common pathologic condition, present in almost 5% of the adult population. Iron deficiency is the most common cause; other mechanisms can be involved, making anaemia a multi-factorial disorder in most cases. Anaemia being a frequent manifestation in the diseases of the gastrointestinal tract, patients are often referred to gastroenterologists. Furthermore, upper and lower endoscopy and enteroscopy are pivotal to the diagnostic roadmap of anaemia. In spite of its relevance in the daily clinical practice, there is a limited number of gastroenterological guidelines dedicated to the diagnosis of anaemia. For this reason, the Italian Association of Hospital Gastroenterologists and E…

EnteroscopyAdultmedicine.medical_specialtySettore MED/09 - Medicina InternaGastrointestinal DiseasesAdult populationAnaemiaInflammatory bowel diseaseEndoscopy Gastrointestinal03 medical and health sciences0302 clinical medicinePaediatric gastroenterologyhemic and lymphatic diseasesInternal medicinemedicineCeliac diseaseHumansIntensive care medicineChildSocieties MedicalHepatologyAnemia Iron-Deficiencybusiness.industryIron deficiencyGastroenterologyEndoscopyAnemiaGuidelineHepatologySmall bowelClinical PracticeChronic anaemiaItalyanaemia; celiac disease; endoscopy; h. pylori; inflammatory bowel disease; iron deficiency; small bowel030220 oncology & carcinogenesisAnaemia; Celiac disease; Endoscopy; H. pylori; Inflammatory bowel disease; Iron deficiency; Small bowel; Hepatology; Gastroenterology030211 gastroenterology & hepatologybusinessH. pyloriBiomarkers
researchProduct